0IGA.L
Emergent BioSolutions Inc. is a life sciences enterprise dedicated to developing and delivering solutions for preparing for and responding to diverse public health threats (PHTs) in the United States. Its mission involves countering unforeseen, intentional, and naturally arising health crises affecting populations. The company's product portfolio addresses a wide spectrum of PHTs, encompassing chemical, biological, radiological, nuclear, and explosive agents (CBRNE), emergent infectious diseases, travel-related health concerns, and immediate emergency medical needs. Among its key commercialized offerings are: Vaccines: BioThrax (for anthrax), ACAM2000 (for smallpox), Vivotif (an oral immuniz...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0IGA.L
According to Emergent BioSolutions Inc.’s latest financial reports and current stock price. The company's current ROE is -35.91%. This represents a change of 170.27% compared to the average of -13.29% of the last 4 quarters.
The mean historical ROE of Emergent BioSolutions Inc. over the last ten years is -9.81%. The current -35.91% ROE has changed 266.08% with respect to the historical average. Over the past ten years (40 quarters), 0IGA.L's ROE was at its highest in in the September 2024 quarter at 22.58%. The ROE was at its lowest in in the June 2024 quarter at -73.29%.
Average
-9.81%
Median
7.45%
Minimum
-117.13%
Maximum
21.13%
Discovering the peaks and valleys of Emergent BioSolutions Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 668.13%
Maximum Annual ROE = 21.13%
Minimum Annual Increase = -211.95%
Minimum Annual ROE = -117.13%
| Year | ROE | Change |
|---|---|---|
| 2025 | 10.07% | -125.50% |
| 2024 | -39.48% | -66.29% |
| 2023 | -117.13% | 668.13% |
| 2022 | -15.25% | -211.95% |
| 2021 | 13.62% | -35.55% |
| 2020 | 21.13% | 322.09% |
| 2019 | 5.01% | -19.27% |
| 2018 | 6.20% | -31.49% |
| 2017 | 9.05% | 4.20% |
| 2016 | 8.69% | -8.79% |
The current ROE of Emergent BioSolutions Inc. (0IGA.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-48.85%
5-year avg
-29.63%
10-year avg
-9.81%
Emergent BioSolutions Inc.’s ROE is less than Esperion Therapeutics, Inc. (1.99%), greater than Verastem, Inc. (-467.49%), greater than Iovance Biotherapeutics, Inc. (-40.51%), greater than Anavex Life Sciences Corp. (-21.11%), greater than Geron Corporation (-30.31%), greater than Myriad Genetics, Inc. (-32.59%), greater than Editas Medicine, Inc. (-196.63%), greater than Aclaris Therapeutics, Inc. (-61.65%), greater than Heron Therapeutics, Inc. (-300.90%), greater than Abeona Therapeutics Inc. (-41.69%),
| Company | ROE | Market cap |
|---|---|---|
| 1.99% | N/A | |
| -467.49% | N/A | |
| -40.51% | N/A | |
| -21.11% | N/A | |
| -30.31% | N/A | |
| -32.59% | N/A | |
| -196.63% | N/A | |
| -61.65% | N/A | |
| -300.90% | N/A | |
| -41.69% | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emergent BioSolutions Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Emergent BioSolutions Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Emergent BioSolutions Inc.'s ROE?
How is the ROE calculated for Emergent BioSolutions Inc. (0IGA.L)?
What is the highest ROE for Emergent BioSolutions Inc. (0IGA.L)?
What is the 3-year average ROE for Emergent BioSolutions Inc. (0IGA.L)?
What is the 5-year average ROE for Emergent BioSolutions Inc. (0IGA.L)?
How does the current ROE for Emergent BioSolutions Inc. (0IGA.L) compare to its historical average?